Literature DB >> 7852117

Relative biological effectiveness of proton medical beam at Moscow synchrotron determined by the Chinese hamster cells assay.

P N Yashkin1, D I Silin, V A Zolotov, V I Kostjuchenko, D F Nichiporov, T P Feoktistova, K S Martirosov, Y I Minakova, V S Khoroshkov, P B Polonski.   

Abstract

PURPOSE: Assessment of relative biological effectiveness (RBE) of the proton medical beam at Moscow synchrotron. METHODS AND MATERIALS: The study was performed at Moscow proton medical facility (Institute for Theoretical and Experimental Physics). Relative biological effectiveness of the synchrotron proton beam was assessed at the entry of the unmodulated 179 MeV beam and in the center of spread out Bragg peak (SOBP), from measurements of the survival of Chinese hamster cells (clone 431). Gamma-radiation of 60Co was used as a reference source.
RESULTS: According to the linear regression model, mean RBE values at 37% survival level were found to be 1.10 +/- 0.04 at the beam entry and 1.14 +/- 0.05 in the center of SOBP. Values of RBE obtained using the linear-quadratic model for 10% and 37% survival levels were 1.09 and 1.07, respectively, at the beam entry and 1.07 and 1.08, respectively, in the center of SOBP.
CONCLUSIONS: The data obtained indicate that (a) the RBE values at the entry of the unmodulated beam and at the center of the SOBP are in close agreement, with an average of about 1.10; (b) protons are radiobiologically somewhat more effective than 60Co gamma rays; and, (c) high pulse dose rate of the medical beam does not significantly affect biological effects of the beam.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7852117     DOI: 10.1016/0360-3016(94)00381-T

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  4 in total

Review 1.  Proton therapy for tumors of the skull base.

Authors:  J E Munzenrider; N J Liebsch
Journal:  Strahlenther Onkol       Date:  1999-06       Impact factor: 3.621

2.  Proton therapy for uveal melanomas and other eye lesions.

Authors:  J E Munzenrider
Journal:  Strahlenther Onkol       Date:  1999-06       Impact factor: 3.621

3.  Comparison of radiobiological effective depths in 65-MeV modulated proton beams.

Authors:  J T Tang; T Inoue; T Inoue; H Yamazaki; S Fukushima; N Fournier-Bidoz; M Koizumi; S Ozeki; K Hatanaka
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

4.  Relative biological effectiveness of the 60-MeV therapeutic proton beam at the Institute of Nuclear Physics (IFJ PAN) in Kraków, Poland.

Authors:  Dorota Słonina; Beata Biesaga; Jan Swakoń; Damian Kabat; Leszek Grzanka; Marta Ptaszkiewicz; Urszula Sowa
Journal:  Radiat Environ Biophys       Date:  2014-07-19       Impact factor: 1.925

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.